Carlos Alberto García López

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

Peter G. Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana‐Arri et al. · The Lancet Infectious Diseases · 2021 · 170 citations · Full text

Dialyzable Leukocyte Extract (Transferon™) Administration in Sepsis: Experience from a Single Referral Pediatric Intensive Care Unit

María Isabel Castrejón-Vázquez, Aldo Arturo Reséndiz‐Albor, Mario Alberto Ynga-Durand et al. · BioMed Research International · 2019 · 17 citations · Full text

Immunohematology, Immunodeficiencies, Immunology +16

Intestinal pseudo-obstruction in patients with systemic lupus erythematosus: A real diagnostic challenge

Carlos Alberto García López · World Journal of Gastroenterology · 2014 · 16 citations · Full text

Efficacy and Safety of the CVnCoV SARS-CoV-2 mRNA Vaccine Candidate: Results from Herald, a Phase 2b/3, Randomised, Observer-Blinded, Placebo-Controlled Clinical Trial in Ten Countries in Europe and Latin America

Peter G. Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana‐Arri et al. · SSRN Electronic Journal · 2021 · 14 citations · Full text

Haemophagocytic lymphohistiocytosis following COVID-19 mRNA vaccination

Vernon Wu, Carlos Alberto García López, Adam Hines et al. · BMJ Case Reports · 2022 · 14 citations · Full text

Vaccination, Vaccine Safety, Suspected Hlh +11